Source: International Congress 2016 – Prognostic variables in lung cancer II



Rating:

Share or cite this content

Citations should be made in the following way:
Xiang Tong (Chengdu, China), Xiang Tong, Yao Ma, Zhipeng Yan, Hong Fan. Association between leptin and risk of lung cancer. Eur Respir J 2016; 48: Suppl. 60, 2869

Member's Comments

No comment yet.

Related content which might interest you: Relationship between risk factors for lung cancer and tumor size Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Symptom-to-treatment intervals in lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Accelerated lung function decline increases the risk of lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Assessment of nutritional status in patients with primary lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Prognostic factors for survival in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 The value of miR221 and miR222 as a biomarker in non small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Epidemiological changes of patients with lung cancer over Years Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 The effect of socioeconomic deprivation on non-small cell lung cancer survival in North East Essex Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Association of the endothelin-1 and endothelin A receptor genetic polymorphisms and non-small cell lung cancer in Taiwan Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Evaluation of lung cancer patients with distant organ metastasis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Multiple primary malignancies in Japanese patients with non-small cell lung cancer Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013